Selective estrogen receptor agonism lacks clinical benefit in rheumatoid arthritis: Comment on the article by van Vollenhoven et al

Publisher： John Wiley & Sons Inc

E-ISSN： 1529-0131|62|12|3832-3833

ISSN： 0004-3591

Source： Arthritis & Rheumatism, Vol.62, Iss.12, 2010-12, pp. : 3832-3833

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The heart in rheumatoid arthritis: Contrasting or misleading data from clinical research? Comment on the article by Giles et al

By  

Arthritis & Rheumatism, Vol. 62, Iss. 12, 2010-12 ,pp. : 3833-3834

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Pharmacology of Selective Estrogen Receptor Modulators

By Haynes B.   Dowsett M.  

Drugs & Aging, Vol. 14, Iss. 5, 1999-05 ,pp. : 323-336

Adis International

Access to resources Recommend Favorite

Oxidative stress in systemic lupus erythematous: Comment on the article by Wang et al

By  

Arthritis & Rheumatism, Vol. 62, Iss. 12, 2010-12 ,pp. : 3835-3836

John Wiley & Sons Inc

Access to resources Recommend Favorite

Estrogen receptor β selective nonsteroidal estrogens: seeking clinical indications

By Mohler Michael L   Narayanan Ramesh   Coss Christopher C   Hu Kejiang   He Yali   Wu Zhongzhi   Hong Seoung-Soo   Hwang Dong Jin   Miller Duane D   Dalton James T  

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 4, 2010-04 ,pp. : 507-534

Informa Healthcare

Access to resources Recommend Favorite

The Discovery and Development of Selective Estrogen Receptor Modulators (SERMs) for Clinical Practice

By  

Current Clinical Pharmacology, Vol. 8, Iss. 2, 2013-01 ,pp. : 135-155

Bentham Science Publishers

Access to resources Recommend Favorite